The read at a glance
Computed from the FY2026 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 4.30 — safe zoneOK
- Earnings-manipulation signal · Beneish M -3.11 — no flag raisedOK
- Earnings quality 88/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2026, as MiniMed Group, Inc. reports it. History and quarterly detail are in the app.
- CGM$1.6B
- Consumables$956.0M
- Pumps$546.0M
- Other$46.0M
Leadership changes
From MiniMed Group, Inc.'s own filings, the day they're filed.
- Courtney Nelson Wills · departureeff. 2026-09-25
- Neuroscience Portfolio · director · departureeff. 2026-07-03
- Scott Cundy · director · departureeff. 2026-07-03
Latest filings
- 8-K · Company announcement2026-09-01
- DEF 14A · Annual proxy (pay & governance)2026-08-21
- 8-K · Company announcement2026-08-05
- 10-K · Annual report2026-06-29
- 8-K · Company announcement2026-06-29
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about MiniMed Group, Inc., every answer cited to the official filings🔒
- The Intelligence Brief — added when MiniMed Group, Inc.'s brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.